×
Shen, Yuanyuan; Xing, Yuncheng; Lin, Haoming; Chen, Siping; Lei, Baiying; Zhou, Jianhua; Liu, Zhong; Chen, Xin

Quantitative analysis of non-alcoholic fatty liver in rats via combining multiple ultrasound parameters. (English) Zbl 1497.92148

Math. Biosci. Eng. 16, No. 5, 4546-4558 (2019).

Cited in 1 Document

MSC:

92C55 Biomedical imaging and signal processing

Keywords:

NAFLD; characteristic parameters; fusion; steatosis stage; quantitative analysis
Cite Review PDF
Full Text: DOI
OA License

References:

[1] P. Angulo, Nonalcoholic Fatty Liver Disease, New Engl. J. Med., 346 (2002), 1221-1231.
[2] G. C. Farrell and C. Z. Larter, Nonalcoholic fatty liver disease: From steatosis to cirrhosis, Hepatology, 43 (2006), S99-S112.
[3] G. Targher, C. P.Day and E. Bonora, Risk ofCardiovascular Disease in Patientswith Nonalcoholic Fatty Liver Disease, New Engl. J. Med., 363 (2010), 1341-1350.
[4] Y. Takahashi and T. Fukusato, Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis, World J. Gastroenterol., 20 (2014), 15539-15548.
[5] N. Zamcheck and R. L. Sidman, Needle biopsy of the liver. I. Its use in clinical and investigative medicine, New Engl. J. Med., 249 (1953), 1020-1029.
[6] Y. Sumida, A. Nakajima and Y. Itoh, Limitations of liver biopsy and non-invasive diagnostic tests for the diagnosis of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis, World J. Gastroenterol., 20 (2014), 475-485.
[7] N. F. Schwenzer, F. Springer, C. Schraml, et al., Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance, J. Hepatol., 51 (2009), 433-445.
[8] S. B. Reeder, I. Cruite, G. Hamilton, et al., Quantitative Assessment of Liver Fat with Magnetic Resonance Imaging and Spectroscopy, J. Magn. Reson. Imaging, 34 (2011), 729-749.
[9] S. Saadeh, Z. M. Younossi, E. M. Remer, et al., The utility of radiological imaging in nonalcoholic fatty liver disease, Gastroenterology, 123 (2002), 745-750.
[10] Y. Guo, C. Dong, H. Lin, et al., Evaluation of Non-alcoholic Fatty Liver Disease Using Acoustic Radiation Force Impulse Imaging Elastography in Rat Models, Ultrasound Med. Biol., 43 (2017), 2619-2628.
[11] C. D. Williams, J. Stengel, M. I. Asike, et al., Prevalence of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Among a Largely Middle-Aged Population Utilizing Ultrasound and Liver Biopsy: A Prospective Study, Gastroenterology, 140 (2011), 124-131.
[12] A. E. Bohte, J. R. van Werven, S. Bipat, et al., The diagnostic accuracy of US, CT, MRI and 1 H-MRS for the evaluation of hepatic steatosis compared with liver biopsy: a meta-analysis, Eur. Radiol., 21 (2011), 87-97.
[13] A. Ozturk, J. R. Grajo, M. S. Gee, et al., Quantitative hepatic fat quantification in non-alcoholic fatty liver disease using ultrasound-based techniques: A review of literature and their diagnostic performance, Ultrasound Med. Biol., 44 (2018), 2461-2475.
[14] M. L. Oelze and J. Mamou, Review of Quantitative Ultrasound: Envelope Statistics and Backscat-ter Coefficient Imaging and Contributions to Diagnostic Ultrasound, IEEE Transa. Ultrason., Ferroelectr. Freq. Control, 63 (2016), 336-351.
[15] F. Destrempes and G. Cloutier, A critical review and uniformized representation of statistical distributions modeling the ultrasound echo envelope, Ultrasound Med. Biol., 36 (2010), 1037-1051.
[16] M. C. Ho, Y. H. Lee, Y. M. Jeng, et al., Relationship between Ultrasound Backscattered Statistics and the Concentration of Fatty Droplets in Livers: An Animal Study, PloS One, 8 (2013), e63543.
[17] P. H. Tsui and Y. L. Wan, Application of Ultrasound Nakagami Imaging for the Diagnosis of Fatty Liver, J. Med. Ultrasound, 24 (2016), 47-49.
[18] Y. L. Wan, D. I. Tai, H. Y. Ma, et al., Effects of fatty infiltration in human livers on the backscat-tered statistics of ultrasound imaging, Proc. Inst. Mech. Eng. Part H-J. Eng. Med., 229 (2015), 419-428.
[19] J. S. Paige, G. S. Bernstein, E. Heba, et al., A Pilot Comparative Study of Quantitative Ultrasound, Conventional Ultrasound, and MRI for Predicting Histology-Determined Steatosis Grade in Adult Nonalcoholic Fatty Liver Disease, Am. J. Roentgenol., 207 (2017), W168-W177.
[20] H. T. Yang, K. F. Chen, Q. Lu, et al., Ultrasonic integrated backscatter in assessing liver steatosis before and after liver transplantation, Hepatobiliary Pancreatic Dis. Int., 13 (2014), 402-408.
[21] S. C. Lin, E. Heba, T. Wolfson, et al., Noninvasive Diagnosis of Nonalcoholic Fatty Liver Disease and Quantification of Liver Fat Using a New Quantitative Ultrasound Technique, Clin. Gastroen-terol. Hepatol., 13 (2015), 1337-1345.
[22] G. Ghoshal, R. J. Lavarello, J. P. Kemmerer, et al., Ex vivo study of quantitative ultrasound parameters in fatty rabbit livers, Ultrasound Med. Biol., 38 (2012), 2238-2248.
[23] D. E. Kleiner, E. M. Brunt, M. Van Natta, et al., Design and validation of a histological scoring system for nonalcoholic fatty liver disease, Hepatology, 41 (2005), 1313-1321.
[24] J. J. Lin, J. Y. Cheng, L. F. Huang, et al., Detecting changes in ultrasound backscattered statistics by using Nakagami parameters: Comparisons of moment-based and maximum likelihood estima-tors, Ultrasonics, 77 (2017), 133-143.
[25] K. Samimi and T. Varghese, Ultrasonic attenuation imaging using spectral cross-correlation and the reference phantom method, 2011 IEEE Int. Ultrason. Symp., (2011), 53-55.
[26] V. Roberjot, S. L. Bridal, P. Laugier, et al., Absolute backscatter coefficient over a wide range of frequencies in a tissue mimicking phantom containing two populations of scatterers, IEEE Trans. Ultrason., Ferroelectr. Freq. Control, 43 (1996), 970-978.
[27] F. L. Lizzi, M. Astor, L. Tian, et al., Ultrasonic spectrum analysis for tissue assays and therapy evaluation, Int. J. Imaging Syst. Technol., 8 (1997), 3-10.
[28] J. Q. Su and J. S. Liu, Linear Combinations of Multiple Diagnostic Markers, Publ. Am. Stat. Assoc., 88 (1993), 1350-1355. · Zbl 0792.62099
[29] Y. Liu, C. F. Dong, G. Yang, et al., Optimal linear combination of ARFI, transient elastography, and APRI for the assessment of fibrosis in chronic hepatitis B, Liver Int., 35 (2015), 816-825.
[30] S. Milić and D.Štimac, Nonalcoholic Fatty Liver Disease/Steatohepatitis: Epidemiology, Patho- genesis, Clinical Presentation and Treatment, Dig. Dis., 30 (2012), 158-162.
[31] C. D. Byrne and G. Targher, NAFLD: A multisystem disease, J. Hepatol., 62 (2015), S47-S64.
[32] R. J. Wong, M. Aguilar, P. Cheung, et al., Nonalcoholic Steatohepatitis Is the Second Leading Etiology of Liver Disease Among Adults Awaiting Liver Transplantation in the United States, Gastroenterology, 148 (2015), 547-555.
[33] R. Bouzitoune, M. Meziri, C. B. Machado, et al., Can early hepatic fibrosis stages be discriminated by combining ultrasonic parameters?, Ultrasonics, 68 (2016), 120-126.
[34] X. Chen, H. Wen, X. Zhang, et al., Development of a Simple Noninvasive Model to Predict Sig-nificant Fibrosis in Patients with Chronic Hepatitis B: Combination of Ultrasound Elastography, Serum Biomarkers, and Individual Characteristics, Clin. Transl. Gastroenterol., 8 (2017), e84.
This reference list is based on information provided by the publisher or from digital mathematics libraries. Its items are heuristically matched to zbMATH identifiers and may contain data conversion errors. In some cases that data have been complemented/enhanced by data from zbMATH Open. This attempts to reflect the references listed in the original paper as accurately as possible without claiming completeness or a perfect matching.